Manning & Napier Group's GSK Position Overview
Manning & Napier Group (via Manning & Napier Advisors LLC) currently holds 1.65 M shares of GSK plc (GSK) worth $81.36 M, representing 1.06% of the portfolio. First purchased in 2024-Q2, this short-term holding has been held for 7 quarters.
Based on 13F filings, Manning & Napier Group has maintained this position in GSK for several quarters, showing initial confidence in the investment. Largest addition occurred in Q3 2025, adding 1.67 M shares. Largest reduction occurred in Q4 2025, reducing 201,265 shares.
Analysis based on 13F filings available since 2013 Q2
Manning & Napier Group's GSK plc (GSK) Holding Value Over Time
Track share changes against reported price movement
Quarterly GSK plc (GSK) Trades by Manning & Napier Group
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2025 | -201,265 | Reduce 10.87% | 1.65 M | $49.30 |
| Q3 2025 | +1.67 M | Add 910.17% | 1.85 M | $43.16 |
| Q2 2025 | -16,708 | Reduce 8.35% | 183,292 | $38.40 |
| Q4 2024 | +50,000 | Add 33.33% | 200,000 | $33.82 |
| Q2 2024 | +150,000 | New Buy | 150,000 | $38.50 |
Manning & Napier Group's GSK plc Investment FAQs
Manning & Napier Group first purchased GSK plc (GSK) in Q2 2024, acquiring 150,000 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Manning & Napier Group has held GSK plc (GSK) for 7 quarters since Q2 2024.
Manning & Napier Group's largest addition to GSK plc (GSK) was in Q3 2025, adding 1,851,569 shares worth $79.91 M.
According to the latest 13F filing for Q4 2025, Manning & Napier Group's firm, Manning & Napier Advisors LLC, owns 1,650,304 shares of GSK plc (GSK), valued at approximately $81.36 M.
As of the Q4 2025 filing, GSK plc (GSK) represents approximately 1.06% of Manning & Napier Group's publicly disclosed stock portfolio, making it one of their key holdings.
Manning & Napier Group's peak holding in GSK plc (GSK) was 1,851,569 shares, as reported at the end of Q3 2025.